Gambia vs Nigeria: Cause of death, by non-communicable diseases, ages 15-59, female
Gambia
38.3%
in 2021
Nigeria
35.6%
in 2021
Gambia rank
167th
Nigeria rank
169th
Cause of death, by non-communicable diseases, ages 15-59, female over time
- Gambia
- Nigeria
How they compare
Gambia currently reports 38.3% against 35.6% in Nigeria, a difference of 2.7%.
That makes Gambia's figure about 1.1 times Nigeria's.
Across all 6 years both countries report, Gambia has been ahead every year.
Gambia ranks 167th and Nigeria ranks 169th of 185 countries.
Gambia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Gambia | Nigeria | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 29.9% | 23.4% | 6.5% | Gambia |
| 2010s | 35.7% | 31.9% | 3.9% | Gambia |
| 2020s | 38.9% | 35.2% | 3.7% | Gambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, female, Gambia or Nigeria?
- Gambia, at 38.3% against 35.6% in Nigeria as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, female between Gambia and Nigeria?
- 2.7%, with Gambia ahead.
- How many years of comparable data are there for Gambia and Nigeria?
- 6 years are reported by both, from 2000 to 2021.
- How do Gambia and Nigeria rank globally for cause of death, by non-communicable diseases, ages 15-59, female?
- Gambia ranks 167th and Nigeria ranks 169th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, female (% of total female deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 15-59 due to non-communicable diseases divided by number of all female deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.